EP3696270A4 - Regulation of nucleic acid molecule expression - Google Patents
Regulation of nucleic acid molecule expression Download PDFInfo
- Publication number
- EP3696270A4 EP3696270A4 EP18866443.7A EP18866443A EP3696270A4 EP 3696270 A4 EP3696270 A4 EP 3696270A4 EP 18866443 A EP18866443 A EP 18866443A EP 3696270 A4 EP3696270 A4 EP 3696270A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- regulation
- nucleic acid
- acid molecule
- molecule expression
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/323—Chemical structure of the sugar modified ring structure
- C12N2310/3231—Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/532—Closed or circular
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/50—Methods for regulating/modulating their activity
- C12N2320/53—Methods for regulating/modulating their activity reducing unwanted side-effects
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017197990 | 2017-10-11 | ||
PCT/JP2018/037975 WO2019074071A1 (en) | 2017-10-11 | 2018-10-11 | Regulation of nucleic acid molecule expression |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3696270A1 EP3696270A1 (en) | 2020-08-19 |
EP3696270A4 true EP3696270A4 (en) | 2021-07-07 |
Family
ID=66100685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18866443.7A Pending EP3696270A4 (en) | 2017-10-11 | 2018-10-11 | Regulation of nucleic acid molecule expression |
Country Status (5)
Country | Link |
---|---|
US (1) | US11298371B2 (en) |
EP (1) | EP3696270A4 (en) |
JP (1) | JP7208911B2 (en) |
CN (1) | CN111201319A (en) |
WO (1) | WO2019074071A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000015779A2 (en) * | 1998-09-15 | 2000-03-23 | Yale University | Molecular cloning using rolling circle amplification |
WO2007044864A2 (en) * | 2005-10-11 | 2007-04-19 | Stratagene California | Target nucleic acid signal detection |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9400522D0 (en) | 1994-02-16 | 1994-02-16 | Ulf Landegren | Method and reagent for detecting specific nucleotide sequences |
KR100397275B1 (en) * | 2001-03-08 | 2003-09-17 | 주식회사 웰진 | Novel high-throughput system for functional genomics using unidirectional antisense cDNA library |
US20070265220A1 (en) * | 2004-03-15 | 2007-11-15 | City Of Hope | Methods and compositions for the specific inhibition of gene expression by double-stranded RNA |
US20080261905A1 (en) | 2004-11-08 | 2008-10-23 | K.U. Leuven Research And Development | Modified Nucleosides for Rna Interference |
KR20090046876A (en) | 2006-08-31 | 2009-05-11 | 도요 세이칸 가부시키가이샤 | Nucleic acid amplification method |
JP5077813B2 (en) | 2006-09-21 | 2012-11-21 | 東洋製罐株式会社 | Nucleic acid amplification method |
JP5296328B2 (en) * | 2007-05-09 | 2013-09-25 | 独立行政法人理化学研究所 | Single-stranded circular RNA and method for producing the same |
ES2873350T3 (en) * | 2007-08-27 | 2021-11-03 | 1Globe Health Inst Llc | Asymmetric interfering RNA compositions and uses thereof |
TW200927177A (en) * | 2007-10-24 | 2009-07-01 | Nat Inst Of Advanced Ind Scien | Lipid-modified double-stranded RNA having potent RNA interference effect |
KR20110110776A (en) | 2008-12-18 | 2011-10-07 | 다이서나 파마수이티컬, 인크. | Extended dicer substrate agents and methods for the specific inhibition of gene expression |
WO2011103394A2 (en) | 2010-02-19 | 2011-08-25 | Agave Pharma Inc. | Methods for gene inhibition |
US8785121B2 (en) | 2010-07-08 | 2014-07-22 | Bonac Corporation | Single-stranded nucleic acid molecule for controlling gene expression |
SG196779A1 (en) | 2010-07-08 | 2014-02-13 | Bonac Corp | Single-strand nucleic acid molecule for controlling gene expression |
DK2718261T3 (en) | 2011-06-08 | 2016-03-29 | Nitto Denko Corp | Compounds to target drug delivery and promote siRNA activity |
WO2013185116A1 (en) | 2012-06-08 | 2013-12-12 | Payne Joseph E | Lipids for therapeutic agent delivery formulations |
CN103333890B (en) * | 2012-12-21 | 2015-04-15 | 厦门成坤生物技术有限公司 | RNA interference preparation used for treating viral hepatitis B |
JP6296434B2 (en) * | 2013-01-25 | 2018-03-20 | 国立研究開発法人理化学研究所 | Construction of functional nucleic acid molecules |
JP6881832B2 (en) | 2016-04-28 | 2021-06-02 | 株式会社 ユーシン・ショウワ | Locking / unlocking device for doors |
-
2018
- 2018-10-11 WO PCT/JP2018/037975 patent/WO2019074071A1/en unknown
- 2018-10-11 EP EP18866443.7A patent/EP3696270A4/en active Pending
- 2018-10-11 US US16/754,595 patent/US11298371B2/en active Active
- 2018-10-11 CN CN201880066149.6A patent/CN111201319A/en active Pending
- 2018-10-11 JP JP2019548241A patent/JP7208911B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000015779A2 (en) * | 1998-09-15 | 2000-03-23 | Yale University | Molecular cloning using rolling circle amplification |
WO2007044864A2 (en) * | 2005-10-11 | 2007-04-19 | Stratagene California | Target nucleic acid signal detection |
Non-Patent Citations (4)
Title |
---|
JONG BUM LEE ET AL.: "Self-assembled RNA interference microsponges for efficient siRNA delivery", NATURE MATERIALS, NATURE PUBLISHING GROUP, LONDON, GB, vol. 11, no. 4, 1 April 2012 (2012-04-01), pages 316 - 322, XP002725915, ISSN: 1476-4660, [retrieved on 20120226], DOI: 10.1038/NMAT3253 * |
LIANGLIANG ZHANG ET AL.: "Circular siRNAs for reducing off-target effects and enhancing long-term gene silencing in cells and mice", MOLECULAR THERAPY: NUCLEIC ACIDS, vol. 10, 1 March 2018 (2018-03-01), US, pages 237 - 244, XP055741899, ISSN: 2162-2531, DOI: 10.1016/j.omtn.2017.12.007 * |
See also references of WO2019074071A1 * |
YAMAKAWA H. ET AL.: "Properties of nicked and circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligodeoxynucleotides", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER, AMSTERDAM, NL, vol. 6, no. 7, 1 July 1998 (1998-07-01), pages 1025 - 1032, XP027411625, ISSN: 0968-0896, [retrieved on 19980701] * |
Also Published As
Publication number | Publication date |
---|---|
EP3696270A1 (en) | 2020-08-19 |
JPWO2019074071A1 (en) | 2021-01-07 |
WO2019074071A1 (en) | 2019-04-18 |
CN111201319A (en) | 2020-05-26 |
US11298371B2 (en) | 2022-04-12 |
US20200261491A1 (en) | 2020-08-20 |
JP7208911B2 (en) | 2023-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL284796B (en) | Regulation of gene expression by aptamer-mediated modulation of alternative splicing | |
IL272850A (en) | Novel artificial nucleic acid molecules | |
SG11201911430PA (en) | Novel nucleic acid molecules | |
EP3294866A4 (en) | Nuclease-mediated regulation of gene expression | |
EP3717645A4 (en) | Sequencing of nucleic acids by emergence | |
EP3472359A4 (en) | Nucleic acid sequencing | |
EP3504229A4 (en) | Regulation of gene expression using engineered nucleases | |
EP3500672A4 (en) | De novo synthesized nucleic acid libraries | |
EP3612152A4 (en) | Topical delivery of nucleic acid compounds | |
EP3129487A4 (en) | Enhanced nucleic acid constructs for eukaryotic gene expression | |
EP3409780A4 (en) | Nucleic acid complex | |
EP3288405B8 (en) | Chemically minimized system for time reduced application of eyelash extensions | |
EP3323893A4 (en) | Beta2gpi gene expression inhibiting nucleic acid complex | |
EP3604528A4 (en) | Cyclic nucleic acid molecule having gene expression control function | |
EP3366773A4 (en) | Nucleic acid complex | |
EP3307755A4 (en) | Identification of genetic modifications | |
EP3380637A4 (en) | Determination of nucleic acid methylation | |
EP3498724A4 (en) | Nucleic acid complex | |
EP3241903A4 (en) | Composition containing nucleic acid molecule stably | |
EP3728206A4 (en) | Template-directed nucleic acid targeting compounds | |
EP3357507A4 (en) | Nucleic acid derivative having immunostimulatory activity | |
EP3411081A4 (en) | Regulation of gene expression through aptamer-modulated polyadenylation | |
EP3469068A4 (en) | Methods to improve genetic transformation of sorghum | |
EP3594345A4 (en) | Nucleic acid capable of inhibiting expression of masp2 | |
EP3271462A4 (en) | System for stable gene expression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200429 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20210609 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 15/113 20100101AFI20210602BHEP Ipc: A61K 31/713 20060101ALI20210602BHEP Ipc: A61K 48/00 20060101ALI20210602BHEP Ipc: A61P 43/00 20060101ALI20210602BHEP |